HCT-ALB在脓毒症相关性脑病早期诊断中的运用价值

李从信; 张大鹏; 沐领捷; 杨吉林; 董丽宏; 王怡洁

doi:10.12259/j.issn.2095-610X.S20220901

HCT-ALB在脓毒症相关性脑病早期诊断中的运用价值

doi: 10.12259/j.issn.2095-610X.S20220901

1.
昆明医科大学第一附属医院ICU，云南昆明　650032
2.
昆明美兆健康体检中心，云南昆明　650032

基金项目: 中华国际医学交流基金会心血管多学科整合思维研究基金资助项目（Z-2016-23-2001-42）；国家自然科学基金资助项目（81960109）；云南省科技厅—昆明医科大学应用基础研究联合专项基金资助项目（202001AY070001-205）

详细信息

作者简介:
李从信（1997～），男，云南玉溪人，在读硕士研究生，主要从事重症消化系统疾病及多器官功能保护临床工作

张大鹏与李从信对本文有同等贡献

通讯作者:
王怡洁，E-mail：81543505@qq.com

中图分类号: R446.1
计量
- 文章访问数: 3057
- HTML全文浏览量: 1855
- PDF下载量: 21
- 被引次数: 0
出版历程
- 收稿日期: 2022-07-26
- 网络出版日期: 2022-09-07
- 刊出日期: 2022-09-29

The Value of HCT-ALB in the Early Diagnosis of Sepsis-associated Encephalopathy

1.
Dept. of ICU，The 1st Affiliated Hospital of Kunming Medical University，Kunming Yunnan, 650032
2.
Kunming Meizhao Health Examination Center，Kunming Yunnan 650032，China

摘要

摘要: 目的寻找简便且可靠的临床定量指标对SAE进行早期诊断是防治SAE的关键。方法收集2020年4月至2022年4月入住ICU脓毒症患者72例，脓毒症脑病（SAE）组31例，无脓毒症脑病（Ne-SAE）组41例。记录患者APACHEⅡ、SOFA、一般资料和临床指标计算CLI、HCT-ALB。采集血浆用ELISA检测NT-proCNP、S100A 8、Tau 蛋白、C5a。结果 SAE组APACHEⅡ评分、SOFA评分较Ne-SAE组明显升高（P < 0.0001），血浆中NT-proCNP和S100A 8较Ne-SAE组明显升高（P < 0.05）。SAE组与Ne-SAE组患者CLI差异无统计学意义（P = 0.823），而2组间HCT-ALB有统计学意义（P = 0.035）。ROC曲线分析结果显示：CLI界值11.04，（AUC = 0.478，95%可信区间0.340～0.616，P = 0.746）敏感度46.34%，特异度80.65%，HCT-ALB界值14.85，（AUC = 0.627，95%可信区间0.491～0.762，P = 0.017）敏感度68.27%，特异度67.74%。结论 HCT-ALB对脓毒症患者发生SAE具有早期诊断价值。
- 脓毒症相关性脑病 /
- 毛细血管渗漏指数 /
- 红细胞压积与白蛋白差值 /
- 早期诊断
Abstract: Objective To find simple and reliable clinical quantitative indicators for the early diagnosis of SAE. Methods Seventy-two septic patients who were admitted to ICU from April 2020 to April 2022, including 31 with sepsis encephalopathy （SAE） and 41 without sepsis encephalopathy （Ne-SAE）, were collected. APACHE Ⅱ, SOFA and general data of Patients were recorded, and CLI, HCT-ALB were calculated based on the clinical assays. Plasma was collected using ELISA to detect NT-proCNP, S100A 8, Tau protein and C5a. Results APACHEⅡscore and SOFA score in SAE group were significantly higher compared with the patients in Ne-SAE group （P < 0.05）. Plasma NT-proCNP and S100A8 levels were significantly higher in the patients with SAE than that of the Ne-SAE group （P < 0.05）. There was no significant difference in CLI between SAE group and NE-SAE group. （P = 0.823）. But , the hct-alb was statistically significant between the two groups （P = 0.035）. The roc curve analysis showed: A cutoff value CLI of 11.04 （AUC = 0.478,95% CI 0.340-0.616, P = 0.746） had 46.34% sensitivity and 80.65% specificity in diagnosing SAE. A cutoff value HCT-ALB of 14.85 （AUC = 0.627,95% CI 0.491-0.762, P = 0.017） had 68.27% sensitivity and 67.74% specificity in diagnosing SAE. Conclusion The HCT-ALB level can be useful in the early diagnosis of SAE in patients with sepsis.
- Sepsis-associated encephalopathy /
- Capillary leakage index /
- The difference of hematocrit and plasma albumin （HCT-ALB） andearly diagnosis /

HTML全文

Figure 1. A ROC curve graph about SAE diagnostic by CLI and HCT-ALB

下载: 全尺寸图片幻灯片

表 1 SAE组与Ne-SAE组患者一般资料比较（$\bar x \pm s $）

Table 1. The comparison of general data between SAE group and Ne-SAE group （$\bar x \pm s $）

一般资料	SAE组	Ne-SAE组	t/χ²	P
（男/女）n（%）	21/10 （67.7/32.3）	28/13（68.3/31.7）	0.002	0.580
年龄（岁）	58.29 ± 12.20	61.41 ± 11.18	−1.129	0.263
APACHEⅡ评分（分）	17.74 ± 2.00	14.78 ± 2.39	5.573	< 0.0001^***
SOFA评分（分）	7.42 ± 2.62	4.63 ± 2.03	5.083	< 0.0001^***
感染部位（n）			0.271	0.873
腹腔	18	26
下颌间隙	9	11
肺部	4	4
病原菌检出（n）			0.072	0.513
有	25	27
无	6	9
^P < 0.05，^P < 0.01，^**P < 0.001。

下载: 导出CSV

表 2 SAE组与Ne-SAE组患者血浆NT-proCNP、S100A 8、C5a和Tau蛋白比较[（$\bar x \pm s $），pg/mL]

Table 2. The comparison of the levels of NT-proCNP, S100A 8, C5a, and Tau proteins between SAE group and Ne-SAE group [（$\bar x \pm s $），pg/mL]

指标	SAE组	Ne-SAE组	t	P
NT-proCNP	1.01 ± 0.19	0.76 ± 0.06	4.162	0.0005^***
S100A 8	1.06 ± 0.22	0.80 ± 0.23	2.760	0.012^*
Tau蛋白	1.03 ± 0.33	0.88 ± 0.25	1.162	0.259
C5a	0.20 ± 0.07	0.16 ± 0.04	1.494	0.151
^P < 0.05，^**P < 0.001。

下载: 导出CSV

表 3 SAE组与Ne-SAE组患者CLI和HCT-ALB比较（$\bar x \pm s $）

Table 3. The comparison of the levels of CLI and HCT-ALB between SAE group and Ne-SAE group （$\bar x \pm s $）

指标	SAE组	Ne-SAE组	t	P
CLI	7.66 ± 3.94	7.02 ± 3.28	−0.224	0.823
HCT-ALB	17.45 ± 6.96	12.76 ± 4.72	2.155	0.035^*
^*P < 0.05。

下载: 导出CSV

表 4 CLI和HCT-ALB对SAE诊断ROC分析结果

Table 4. The results of ROC analysis about SAE diagnostic by CLI and HCT-ALB

指标	界值	AUC	95%可信区间	敏感度（%）	特异度（%）
CLI	11.04	0.478	0.340～0.616	46.34	80.65
HCT-ALB	14.85	0.627	0.491～0.762	68.27	67.74

下载: 导出CSV

参考文献(19)

[1]	Tauber S C,Djukic M,Gossner J,et al. Sepsis-associated encephalopathy and septic encephalitis:An update[J]. Expert Rev Anti Infect Ther,2021,19(2):215-231. doi: 10.1080/14787210.2020.1812384
[2]	Chen J,Shi X,Diao M,et al. A retrospective study of sepsis-associated encephalopathy:Epidemiology,clinical features and adverse outcomes[J]. BMC Emerg Med,2020,20(1):77. doi: 10.1186/s12873-020-00374-3
[3]	Annane D,Sharshar T. Cognitive decline after sepsis[J]. Lancet Respir Med,2015,3(1):61-69.
[4]	Singer M,Deutschman C S,Seymour C W,et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3)[J]. JAMA,2016,315(8):801-810. doi: 10.1001/jama.2016.0287
[5]	Cordemans C,De Laet I,Van Regenmortel N,et al. Fluid management in critically ill patients:The role of extravascular lung water,abdominal hypertension,capillary leak,and fluid balance[J]. Ann Intensive Care,2012,2(Suppl 1):S11-S12.
[6]	Dai D M,Wang D,Hu D,et al. Difference in hematocrit and plasma albumin levels as an additional biomarker in the diagnosis of infectious disease[J]. Arch Med Sci,2020,16(3):522-530. doi: 10.5114/aoms.2019.86898
[7]	Tauber S C,Eiffert H,Bruck W,et al. Septic encephalopathy and septic encephalitis[J]. Expert Rev Anti Infect Ther,2017,15(2):121-132. doi: 10.1080/14787210.2017.1265448
[8]	Pensato U,Muccioli L,Cani I,et al. Brain dysfunction in COVID-19 and CAR-T therapy:Cytokine storm-associated encephalopathy[J]. Ann Clin Transl Neurol,2021,8(4):968-979. doi: 10.1002/acn3.51348
[9]	Gofton T E,Young G B. Sepsis-associated encephalopathy[J]. Nat Rev Neurol,2012,8(10):557-566. doi: 10.1038/nrneurol.2012.183
[10]	Ehler J,Saller T,Wittstock M,et al. Diagnostic value of NT-proCNP compared to NSE and S100B in cerebrospinal fluid and plasma of patients with sepsis-associated encephalopathy[J]. Neurosci Lett,2019,692(10):167-173.
[11]	Heming N,Mazeraud A,Verdonk F,et al. Neuroanatomy of sepsis-associated encephalopathy[J]. Crit Care,2017,21(1):65. doi: 10.1186/s13054-017-1643-z
[12]	Zhang L N,Wang X H,Wu L,et al. Diagnostic and predictive levels of calcium-binding protein A8 and tumor necrosis factor receptor-associated factor 6 in sepsis-associated encephalopathy:A prospective observational study[J]. Chin Med J (Engl),2016,129(14):1674-1681. doi: 10.4103/0366-6999.185860
[13]	Li X L,Xie J F,Ye X Y,et al. Value of cerebral hypoxic-ischemic injury markers in the early diagnosis of sepsis associated encephalopathy in burn patients with sepsis[J]. Zhonghua Shao Shang Za Zhi,2022,38(1):21-28.
[14]	Orhun G,Tüzün E,Özcan P E,et al. Association between inflammatory markers and cognitive outcome in patients with acute brain dysfunction due to sepsis[J]. Noro Psikiyatr Ars,2019,56(1):63-70.
[15]	李永胜,梅华鲜,黄中会,等. 毛细血管渗漏指数对脓毒症危险分层及预后评估的价值[J]. 临床急诊杂志,2017,18(5):362-365. doi: 10.13201/j.issn.1009-5918.2017.05.010
[16]	王晓晖,徐云海,张波. 毛细血管渗漏指数对脓毒症合并ARDS早期诊断及预后的评估价值[J]. 临床急诊杂志,2020,21(5):350-354. doi: 10.13201/j.issn.1009-5918.2020.05.003
[17]	Dai D M,Cao J,Yang H M,et al. Hematocrit and plasma albumin levels difference may be a potential biomarker to discriminate preeclampsia and eclampsia in patients with hypertensive disorders of pregnancy[J]. Clin Chim Acta,2017,464(1):218-222.
[18]	Clyne B,Olshaker J S. The C-reactive protein[J]. J Emerg Med,1999,17(6):1019-25. doi: 10.1016/S0736-4679(99)00135-3
[19]	Pierrakos C,Velissaris D,Bisdorff M,et al. Biomarkers of sepsis:Time for a reappraisal[J]. Crit Care,2020,24(1):287. doi: 10.1186/s13054-020-02993-5

相关文章(20)

[1]	牛俊杰, 姬文娟, 于拽拽. 肠道菌群、血清ET、PCT水平与脓毒症病情程度、预后的相关性, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240420
[2]	武彧, 杨德兴, 王虹, 王强, 周维钰, 唐杰夫, 王振方, 付凯, 刘荣. 脓毒性休克患者早期动、静脉血乳酸相关性及乳酸、乳酸清除率的预后评估价值, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210927
[3]	许汪斌, 代冬梅, 何美娥, 肖李乐云, 王飞, 杨磊, 唐坤. 红细胞压积与白蛋白差值在继发性腹腔感染患者病程中的变化, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210519
[4]	世淑兰, 戴熙廷, 赵广周, 李小娟, 李荣杰, 麻明彪. 16SrRNA基因检测在儿童细菌性脑膜炎早期诊断中的应用, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210522
[5]	张颖, 牛小群. 肺泡灌洗液G和GM试验对早期诊断AECOPD患者并发侵袭性肺真菌感染的诊断价值, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20201217
[6]	李雪芹, 刁永书, 刘敏, 罗燕, 张华, 马登艳. 早期诊断尿毒症住院患者心理痛苦调查及其影响因素, 昆明医科大学学报.
[7]	张金枝, 张潇, 刘真真. 脑小血管病患者TCD检测脑血流改变与认知功能障碍的相关性研究, 昆明医科大学学报.
[8]	何玲, 肖晶, 杨必彦, 王松. 新生儿脓毒症休克血清AT与PCT、sh-CRP相关性及应用价值, 昆明医科大学学报.
[9]	陈先维, 陆向东, 王永峰, 赵轶波, 杨旭, 王文轩, 范彦鑫, 张晖, 赵斌. 骨关节炎患者单核细胞/淋巴细胞比值、红细胞压积与疾病活动度的相关性, 昆明医科大学学报.
[10]	刘明敏, 王丽春, 梁喜, 杨蕊. 超声引导下乳腺微小病变活检应用于乳腺癌早期诊断, 昆明医科大学学报.
[11]	梅茸, 陈文利, 张凤丽, 孟强, 赵忠, 丁里. 脑CT灌注成像在血管性认知功能障碍早期诊断中的应用, 昆明医科大学学报.
[12]	潘宝龙, 巫玲, 潘丽, 张园园, 李俊娥, 詹学良. 相关实验室指标在早期类风湿性关节炎中的应用, 昆明医科大学学报.
[13]	何建辉. 云南省某农村地区体重相关指数分布与心血管疾病的关系, 昆明医科大学学报.
[14]	龙琼华. 2型糖尿病对老年高血压患者颈动脉内膜中层厚度与左心室质量指数的影响及相关性, 昆明医科大学学报.
[15]	唐爱群. 原发性高血压患者尿白蛋白/尿肌酐比与心踝血管指数的相关性, 昆明医科大学学报.
[16]	张红. 外周血红细胞和血红蛋白因素与高原地区高尿酸血症患者相关性分析, 昆明医科大学学报.
[17]	陈孝红. 2型糖尿病肾病患者血清PEDF、CRP、IL-6水平与尿白蛋白排泄率相关性分析, 昆明医科大学学报.
[18]	王兴宁. 尿微量白蛋白与肌酐比值在2型糖尿病早期肾损伤中的应用, 昆明医科大学学报.
[19]	郭皓. 高血压患者2种动态动脉硬化指数与早期肾损害的相关性, 昆明医科大学学报.
[20]	. 新生儿缺血缺氧性脑病的CT与临床诊断价值分析, 昆明医科大学学报.